MN Services Vermogensbeheer’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $54.3M | Sell |
108,215
-37,900
| -26% | -$18.2M | 0.41% | 51 |
|
|
2026
Q1 | $71.8M | Sell |
146,115
-100
| -0.1% | -$54.3K | 0.47% | 40 |
|
|
2025
Q4 | $84.7M | Buy |
146,215
+2,715
| +2% | +$1.54M | 0.52% | 31 |
|
|
2025
Q3 | $69.6M | Buy |
143,500
+2,400
| +2% | +$1.12M | 0.45% | 42 |
|
|
2025
Q2 | $57.2M | Sell |
141,100
-1,200
| -0.8% | -$502K | 0.4% | 51 |
|
|
2025
Q1 | $70.8M | Sell |
142,300
-10,300
| -7% | -$5.58M | 0.55% | 33 |
|
|
2024
Q4 | $79.4M | Buy |
152,600
+3,100
| +2% | +$1.7M | 0.53% | 32 |
|
|
2024
Q3 | $92.5M | Sell |
149,500
-3,200
| -2% | -$1.89M | 0.65% | 25 |
|
|
2024
Q2 | $84.4M | Sell |
152,700
-3,000
| -2% | -$1.72M | 0.61% | 29 |
|
|
2024
Q1 | $90.5M | Sell |
155,700
-26,900
| -15% | -$15.1M | 0.66% | 28 |
|
|
2023
Q4 | $96.9M | Sell |
182,600
-4,800
| -3% | -$2.32M | 0.87% | 24 |
|
|
2023
Q3 | $94.9M | Buy |
187,400
+3,200
| +2% | +$1.71M | 0.91% | 21 |
|
|
2023
Q2 | $96.1M | Sell |
184,200
-10,500
| -5% | -$5.67M | 0.9% | 23 |
|
|
2023
Q1 | $112M | Buy |
194,700
+6,800
| +4% | +$3.83M | 1.16% | 16 |
|
|
2022
Q4 | $103M | Sell |
187,900
-29,300
| -13% | -$15.5M | 1.16% | 15 |
|
|
2022
Q3 | $110M | Sell |
217,200
-13,900
| -6% | -$7.78M | 1.16% | 17 |
|
|
2022
Q2 | $126M | Sell |
231,100
-50,800
| -18% | -$28M | 1.17% | 17 |
|
|
2022
Q1 | $167M | Sell |
281,900
-18,600
| -6% | -$10.7M | 1.11% | 17 |
|
|
2021
Q4 | $201M | Buy |
300,500
+6,200
| +2% | +$3.87M | 1.17% | 15 |
|
|
2021
Q3 | $168M | Buy |
294,300
+4,900
| +2% | +$2.69M | 1.04% | 16 |
|
|
2021
Q2 | $123M | Buy |
+289,400
| New | +$137M | 0.96% | 21 |
|
|
2019
Q3 | – | Sell |
-68,347
| Closed | -$20.1M | – | 578 |
|
|
2019
Q2 | $20.1M | Sell |
68,347
-800
| -1% | -$220K | 0.24% | 101 |
|
|
2019
Q1 | $18.9M | Buy |
69,147
+800
| +1% | +$199K | 0.22% | 109 |
|
|
2018
Q4 | $13.4M | Buy |
68,347
+4,100
| +6% | +$962K | 0.2% | 111 |
|
|
2018
Q3 | $15.7M | Hold |
64,247
| – | – | 0.37% | 59 |
|
|
2018
Q2 | $13.3M | Buy |
64,247
+1,100
| +2% | +$233K | 0.33% | 61 |
|
|
2018
Q1 | $13M | Buy |
63,147
+900
| +1% | +$189K | 0.34% | 63 |
|
|
2017
Q4 | $9.84M | Sell |
62,247
-2,300
| -4% | -$441K | 0.31% | 70 |
|
|
2017
Q3 | $12.2M | Buy |
64,547
+200
| +0.3% | +$36.2K | 0.32% | 67 |
|
|
2017
Q2 | $11.2M | Buy |
64,347
+53,812
| +511% | +$9.04M | 0.31% | 72 |
|
|
2017
Q1 | $1.51M | Buy |
10,535
+355
| +3% | +$54.3K | 0.29% | 77 |
|
|
2016
Q4 | $1.36M | Hold |
10,180
| – | – | 0.28% | 82 |
|
|
2016
Q3 | $1.62M | Buy |
10,180
+143
| +1% | +$22K | 0.32% | 70 |
|
|
2016
Q2 | $1.33M | Buy |
10,037
+63
| +0.6% | +$9.3K | 0.31% | 72 |
|
|
2016
Q1 | $1.24M | Buy |
+9,974
| New | +$1.34M | 0.29% | 78 |
|
Other funds holding TMO
MN Services Vermogensbeheer's TMO Position: Q2 2026 in Review
MN Services Vermogensbeheer reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q2 2026, selling an estimated $18.2M and leaving 108,215 shares worth $54.3M. The position accounts for 0.41% of the portfolio, ranked #51.
MN Services Vermogensbeheer first reported a position in TMO in Q1 2016 and has held it in 35 quarters since. The position peaked at $201M in Q4 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- MN Services Vermogensbeheer held 108,215 shares of Thermo Fisher Scientific worth $54.3M as of Q2 2026.
- MN Services Vermogensbeheer sold 37,900 Thermo Fisher Scientific shares in Q2 2026, an estimated $18.2M.
- Thermo Fisher Scientific made up 0.41% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #51 holding.
- MN Services Vermogensbeheer first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 35 quarters since.
- MN Services Vermogensbeheer's Thermo Fisher Scientific position peaked at $201M in Q4 2021.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.